| Characteristic | Cohort (n = 11) |
| Age (years) | 70.1 ± 15.4 |
| Male sex | 7 (64%) |
| Ethnicity |
|
| Caucasian | 10 (91%) |
| African | 1 (9%) |
| Vintage (months) | 52 ± 47.25 |
| Diabetes mellitus | 0 (0%) |
| LVH | 7 (70%) |
| Diastolic heart failure | 8 (89%) |
| Antihypertensive drugs (N) | 3.1 ± 1.5 |
| Type antihypertensive drug |
|
| ACEI or ARB | 8 (73%) |
| CCB | 9 (82%) |
| Beta-blocker | 6 (54%) |
| Diuretic | 4 (36%) |
| Moxonidine | 7 (64%) |
| ESAs | 10 (91%) |